THZ1 targeting CDK7 suppresses STAT transcriptional activity and sensitizes T-cell lymphomas to BCL2 inhibitors.
Cayrol F, Praditsuktavorn P, Fernando TM, Kwiatkowski N, Marullo R, Calvo-Vidal MN, Phillip J, Pera B, Yang SN, Takpradit K, Roman L, Gaudiano M, Crescenzo R, Ruan J, Inghirami G, Zhang T, Cremaschi G, Gray NS, Cerchietti L.
Cayrol F, et al. Among authors: cremaschi g.
Nat Commun. 2017 Jan 30;8:14290. doi: 10.1038/ncomms14290.
Nat Commun. 2017.
PMID: 28134252
Free PMC article.